Luminescent and Time-Resolved Determination of Gemifloxacin Mesylate in Pharmaceutical Formulations and Spiked Blood Plasma Samples Using a Lanthanide Complex as a Probe

Gasser M Khairy,Rania M Goda,Zeinab M Anwar,Mohamed M Aboelnga,Axel Duerkop,Rania M. Goda,Mohamed M. Aboelnga
DOI: https://doi.org/10.1039/d4ay00236a
IF: 3.1
2024-03-27
Analytical Methods
Abstract:A novel luminescence-based analytical methodology was established employing a europium (III) complex with 3-allyl-2-hydroxybenzohydrazide (HAZ) as the coordinating ligand for the quantification of gemifloxacin mesylate (GMF) in pharmaceutical preparations and human plasma samples enhanced with the compound. The stoichiometry of the europium complex with HAZ was determined via a Job's plot and exhibits a metal-to-ligand ratio of 1:2. The analytical procedure relies on a rapid and significant enhancement of luminescence by the Eu(AZ) 2 complex when it interacts with gemifloxacin mesylate which allows for the rapid detection of 96 samples within in approximately 2 minutes. The thermodynamic parameters of the complexation of GMF with Eu(AZ) 2 were evaluated and showed that the complexation of GMF is spontaneous with a negative ∆G. The binding constant K is 4.27 · 10 -5 L mol -1 and DFT calculations support GMF binding and the formation of Eu(AZ) 2 -GMF without further ligand exchange. The calibration graph for the luminescence quantitation of GMF was linear over a wide range of 0.11–16 μg mL -1 (2.3 · 10 -7 - 3.3 · 10 -5 mol L -1 ), with a limit of quantification (LOQ) of 110 ng mL -1 (230 nmol L -1 ) and a detection limit (LOD) of 40 ng mL -1 (82 nmol L -1 ). The proposed method showed a good accuracy as to recoveries of on average 99% with relative standard deviations of less than 5 % in spiking experiments, even in complex pharmaceutical dosage forms like tablets and in human blood plasma. Here, the ability of suppression of the luminescence background by using the long lag times of the lanthanide probe in a time-resolved detection scheme provides reliable and precise results which suggests its use in further real or patient samples.
spectroscopy,chemistry, analytical,food science & technology
What problem does this paper attempt to address?